The CADD Symposium will be held on Wednesday, May 20, 2020, at the University of Maryland School of Pharmacy in Pharmacy Hall, Room N103.
EVENT UPDATE: Due to the COVID-19 (Novel Coronavirus) pandemic, the CADD Symposium has been CANCELLED. For more information about COVID-19 and its impact on the School of Pharmacy community, please visit the School's COVID-19 preparedness website.
About the Event:
This symposium is designed to facilitate collaborations between the CADD Center at the School of Pharmacy and researchers at UMB, throughout the University System of Maryland, and beyond. The symposium is appropriate for all scientists interested in the field of drug design involving both small molecules and protein-based drugs, including graduate students, postdoctoral fellows, and researchers and educators from academia, government, and industry. A collection of local and external speakers, including computational chemists and experimentalists, will present recent developments in drug design and development, as well as emerging areas of biology that may represent future drug discovery targets.
The symposium is free to attend, but registration is required. Visit this webpage to register.
Space is also available for attendees to present posters. Poster submission may be completed while registering for the meeting. Attendees may also submit a poster after registering or submit a second poster by visiting this webpage.
About the Sponsors:
|The University of Maryland School of Pharmacy, the fourth oldest school of pharmacy in the United States, leads pharmacy education, scientific discovery, patient care, and community engagement in the state of Maryland and beyond.|
|||SilcsBio provides software and services for unlocking the full potential of computer driven drug design. Its algorithms for mapping proteins offer a level of detail that has never before been seen. From its highly accurate free energy maps to conformational nuances revealing hidden pockets of opportunity, SilcsBio uncovers a whole new world of possibilities|
|Early Charm Ventures is a seed stage investment and technology commercialization company that works with companies in the earliest stages of commercialization, specializing in assisting entrepreneurial-minded scientists who have a new technology or product and want to take it to the marketplace.|
|Rasio Therapeutics, Inc., a Maryland-based drug development company, creates novel medicines using a cutting edge-computer aided drug design technology. Our mission addresses unmet patient needs through modeling of novel/deep cell binding regions. Rasio designs and develops molecules to fit those regions and enhance treatment for cancer and other diseases.|